Top

Archives of Osteoporosis

Published in:

01-12-2019 | Hepatitis B | Original Article

The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort

Authors: Chanyang Min, Woo Jin Bang, Miyoung Kim, Dong Jun Oh, Hyo Geun Choi

Published in: Archives of Osteoporosis | Issue 1/2019

Abstract

Summary

The prevalence of hepatitis B was higher in osteoporosis patients than the control group, especially in females. However, the prevalence of hepatitis C was not different. The matching for various factors improved to have same conditions between osteoporosis patients and the control group.

Purpose

Although chronic liver disease, including hepatitis B and hepatitis C, has been associated with osteoporosis in previous studies, the evidence was insufficient, and some findings were inconsistent. The aim of this study was to evaluate the relationship between hepatitis B or hepatitis C and osteoporosis.

Methods

We used the Korean National Health Insurance Service-National Sample Cohort with ≥ 50-year-old participants from 2002 to 2013. Age was determined at osteoporosis diagnosis. We extracted 68,492 osteoporosis patients (ICD-10 codes E7001–E7004, HC341–HC345) with a 68,492-member control group at a ratio of 1:1 by age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia. We analyzed previous histories of hepatitis B (ICD-10 codes B18.0–B18.1) and hepatitis C (ICD-10 code B18.2) in the osteoporosis patients and control groups. The logistic regression with the crude and adjusted model was analyzed. Additionally, subgroup analyses divided by age and sex were performed.

Results

The adjusted odds ratios for hepatitis B and hepatitis C were 1.19 (95% confidence interval (CI) = 1.11–1.28, P < 0.001) and 1.04 (95% CI = 0.90–1.19, P > 0.05), respectively, in osteoporosis patients. Subgroup analyses showed that the risk of hepatitis B was higher in osteoporosis patients in female groups but not in male groups.

Conclusion

Hepatitis B virus infection might be a risk factor for osteoporosis.

Available only for authorised users

World Health Organization (2018) Hepatitis C https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

World Health Organization (2018) Hepatitis B https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b

Cho EJ, Kim SE, Suk KT, An J, Jeong SW, Chung WJ, Kim YJ (2017) Current status and strategies for hepatitis B control in Korea. Clin Mol Hepatol 23(3):205–211. https://doi.org/10.3350/cmh.2017.0104 CrossRefPubMedPubMedCentral

Jeong S-H, Jang ES, Choi HY, Kim K-A, Chung W, Ki M (2017) Current status of hepatitis C virus infection and countermeasures in South Korea. Epidemiol Health 39

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis (1993). Am J Med 94 (6):646–650

Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis F (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381. https://doi.org/10.1007/s00198-014-2794-2 CrossRefPubMedPubMedCentral

Wright NC, Saag KG, Dawson-Hughes B, Khosla S, Siris ES (2017) The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int 28(4):1225–1232. https://doi.org/10.1007/s00198-016-3865-3 CrossRefPubMed

Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS (2012) The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008-2009. J Bone Miner Res 27(9):1879–1886. https://doi.org/10.1002/jbmr.1635 CrossRefPubMed

Guarino M, Loperto I, Camera S, Cossiga V, Di Somma C, Colao A, Caporaso N, Morisco F (2016) Osteoporosis across chronic liver disease. Osteoporos Int 27(6):1967–1977. https://doi.org/10.1007/s00198-016-3512-z CrossRefPubMed

10.

Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER (1995) Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21(2):389–392PubMed

11.

van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA (2001) Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 11(1–3):199–226PubMed

12.

Baeg MK, Yoon SK, Ko SH, Han KD, Choi HJ, Bae SH, Choi JY, Choi MG (2016) Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys. Hepatol Int 10(3):470–477. https://doi.org/10.1007/s12072-015-9672-7 CrossRefPubMed

13.

Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio AR, Lo Re V 3rd (2014) Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection. J Hepatol 61(2):210–218. https://doi.org/10.1016/j.jhep.2014.04.001 CrossRefPubMedPubMedCentral

14.

Chen CH, Lin CL, Kao CH (2015) Association between chronic hepatitis B virus infection and risk of osteoporosis: a Nationwide population-based study. Medicine (Baltimore) 94(50):e2276. https://doi.org/10.1097/MD.0000000000002276 CrossRef

15.

Huang Z, Wei H, Cheng C, Yang S, Wang J, Liu X (2017) Low bone mineral density in chronic hepatitis B virus infection: a case-control study. Pak J Med Sci 33(2):457–461. https://doi.org/10.12669/pjms.332.12099 CrossRefPubMedPubMedCentral

16.

Chen CH, Lin CL, Kao CH (2015) Relation between hepatitis C virus exposure and risk of osteoporosis: a Nationwide population-based study. Medicine (Baltimore) 94(47):e2086. https://doi.org/10.1097/MD.0000000000002086 CrossRef

17.

Gaudio A, Pennisi P, Muratore F, Bertino G, Ardiri A, Pulvirenti I, Tringali G, Fiore CE (2012) Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: a peripheral quantitative computed tomography (pQCT) study. Eur J Intern Med 23(7):656–660. https://doi.org/10.1016/j.ejim.2012.05.011 CrossRefPubMed

18.

Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC (2012) Association between chronic hepatitis C virus infection and bone mineral density. Calcif Tissue Int 91(6):423–429. https://doi.org/10.1007/s00223-012-9653-y CrossRefPubMed

19.

Orsini LG, Pinheiro MM, Castro CH, Silva AE, Szejnfeld VL (2013) Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C. PLoS One 8(11):e81652. https://doi.org/10.1371/journal.pone.0081652 CrossRefPubMedPubMedCentral

20.

Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS (2002) Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277(4):2695–2701. https://doi.org/10.1074/jbc.M106339200

21.

Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG (2004) Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 89(9):4325–4330. https://doi.org/10.1210/jc.2004-0077 CrossRefPubMed

22.

Lee J, Lee JS, Park SH, Shin SA, Kim K (2016) Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol:dyv319. https://doi.org/10.1093/ije/dyv319

23.

National Health Insurance Sharing Service. National sample cohort. https://nhiss.nhis.or.kr/. Accessed October 24 2017

24.

Pelazas-Gonzalez R, Gonzalez-Reimers E, Aleman-Valls MR, Santolaria-Fernandez F, Lopez-Prieto J, Gonzalez-Diaz A, Gomez-Sirvent JL, de la Vega-Prieto MJ (2013) Bone alterations in hepatitis C virus infected patients. Eur J Intern Med 24 (1):92–96. doi:https://doi.org/10.1016/j.ejim.2012.09.007

25.

Gaudio A, Lasco A, Morabito N, Atteritano M, Vergara C, Catalano A, Fries W, Trifiletti A, Frisina N (2005) Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role? J Endocrinol Investig 28(8):677–682CrossRef

26.

Lopez-Larramona G, Lucendo AJ, Gonzalez-Castillo S, Tenias JM (2011) Hepatic osteodystrophy: an important matter for consideration in chronic liver disease. World J Hepatol 3(12):300–307. https://doi.org/10.4254/wjh.v3.i12.300 CrossRefPubMedPubMedCentral

27.

Diez Ruiz A, Santos Perez JL, Lopez Martinez G, Gonzalez Calvin J, Gil Extremera B, Gutierrez Gea F (1993) Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis. Alcohol Alcohol 28(3):319–323PubMed

28.

Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI (1991) Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13(2):267–276CrossRefPubMed

29.

Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21(10):1648–1656. https://doi.org/10.1359/jbmr.060707 CrossRefPubMed

30.

Gatta A, Verardo A, Di Pascoli M, Giannini S, Bolognesi M (2014) Hepatic osteodystrophy. Clin Cases Miner Bone Metab 11(3):185–191PubMedPubMedCentral

31.

Pignata S, Daniele B, Galati MG, Esposito G, Vallone P, Fiore F, Ricchi P, Pergola M (1997) Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma. Eur J Gastroenterol Hepatol 9(3):283–286CrossRefPubMed

32.

Bolland MJ, Grey A, Reid IR (2015) Skeletal health in adults with HIV infection. Lancet Diabetes Endocrinol 3(1):63–74. https://doi.org/10.1016/s2213-8587(13)70181-5 CrossRefPubMed

33.

Farhat GN, Cauley JA (2008) The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab 5(1):19–34PubMedPubMedCentral

34.

Gillis J, Smieja M, Cescon A, Rourke SB, Burchell AN, Cooper C, Raboud JM (2014) Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther 19(3):309–317. https://doi.org/10.3851/imp2724 CrossRefPubMed

35.

Raison CL, Miller AH (2011) Is depression an inflammatory disorder? Curr Psychiatry Rep 13(6):467–475. https://doi.org/10.1007/s11920-011-0232-0 CrossRefPubMedPubMedCentral

Title: The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort
Authors: Chanyang Min
Woo Jin Bang
Miyoung Kim
Dong Jun Oh
Hyo Geun Choi
Publication date: 01-12-2019
Publisher: Springer London
Keywords: Hepatitis B
Dyslipidemia
Osteoporosis
Hepatitis C
Osteoporosis
Published in: Archives of Osteoporosis / Issue 1/2019
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-019-0590-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort

Abstract

Summary

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2019

The effects of short-term back extensor strength training in postmenopausal osteoporotic women with vertebral fractures: comparison of supervised and home exercise program

Associations between the lipid profile and the lumbar spine bone mineral density and trabecular bone score in elderly Iranian individuals participating in the Bushehr Elderly Health Program: a population-based study

Physical activity modifies the effect of calcium supplements on bone loss in perimenopausal and postmenopausal women: subgroup analysis of a randomized controlled trial

An investigation into the effects of kinesiotaping for posture correction on kyphosis angle, pain, and balance in patients with postmenopausal osteoporosis-associated thoracic kyphosis

The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options

Incidence and excess mortality of hip fractures in a predominantly Caucasian population in the South of Brazil